{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:31:19Z","timestamp":1759847479058},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.diagmicrobio.2024.116435","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T22:23:20Z","timestamp":1720736600000},"page":"116435","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study"],"prefix":"10.1016","volume":"110","author":[{"given":"Weihe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peixuan","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007083","article-title":"The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases","volume":"13","author":"Baldwin","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116435_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055672","article-title":"Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.meegid.2017.10.013","article-title":"The new phylogeny of the genus Mycobacterium: the old and the news","volume":"56","author":"Tortoli","year":"2017","journal-title":"Infect Genet Evol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116435_bib0004","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jinf.2016.08.020","article-title":"The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis","volume":"73","author":"Yu","year":"2016","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01915-18","article-title":"In vitro and intracellular activity of imipenem combined with tedizolid, rifabutin, and avibactam against Mycobacterium abscessus","volume":"63","author":"Le Run","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116435_bib0006","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/dku431","article-title":"Time-kill kinetics of antibiotics active against rapidly growing mycobacteria","volume":"70","author":"Ferro","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chest.2017.04.166","article-title":"Microbiological and clinical outcomes of treating non-mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis","volume":"152","author":"Diel","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1243457","article-title":"Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs","volume":"13","author":"Gu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0009","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British thoracic society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0011","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2023.08.025","article-title":"Outcomes of intermittent multidrug IV therapy for refractory mycobacterium abscessus pulmonary disease","volume":"165","author":"Im","year":"2024","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116435_bib0012","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1684-1182(10)60063-1","article-title":"Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing","volume":"43","author":"Huang","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1592\/phco.24.1.58.34808","article-title":"Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria","volume":"24","author":"Guay","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.diagmicrobio.2012.12.004","article-title":"Tigecycline: an update","volume":"75","author":"Stein","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"year":"2023","series-title":"Performance standards for susceptibility testingof mycobacteria, Nocardiae spp., and other aerobic actinomycetes.2nd edition.CLSI supplement M24s","key":"10.1016\/j.diagmicrobio.2024.116435_bib0015"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02549-22","article-title":"Antimicrobial susceptibility testing using the MYCO test system and MIC distribution of 8 drugs against clinical isolates of nontuberculous mycobacteria from Shanghai","volume":"11","author":"Ying","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116435_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11050571","article-title":"Treatment outcome in patients with mycobacterium abscessus complex lung disease: the impact of tigecycline and amikacin","volume":"11","author":"Yang","year":"2022","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00118-22","article-title":"Genomic analysis of mycobacterium abscessus complex isolates from patients with pulmonary infection in China","volume":"10","author":"Jin","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116435_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11090969","article-title":"High rates of antimicrobial resistance in rapidly growing mycobacterial infections in Taiwan","volume":"11","author":"Tu","year":"2022","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116435_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12081976","article-title":"New RAPMYCOI SensititreTM antimicrobial susceptibility test for atypical rapidly growing mycobacteria (RGM)","volume":"12","author":"Borek","year":"2022","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0021","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkaa520","article-title":"In vitrosusceptibility ofMycobacterium abscessuscomplex and feasibility of standardizing treatment regimens","volume":"76","author":"Chew","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0022","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jgar.2021.02.024","article-title":"Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China","volume":"25","author":"Guo","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0023","article-title":"Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey","volume":"10","author":"Liu","year":"2021","journal-title":"Infect Dis Pov"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0024","article-title":"Bloodstream infections with rapidly growing nontuberculous mycobacteria","volume":"25","author":"Comba","year":"2021","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0025","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2147\/IDR.S252485","article-title":"Antimicrobial susceptibility of Mycobacterium abscessus complex clinical isolates from a Chinese tertiary hospital","volume":"13","author":"Guo","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116435_bib0026","first-page":"58","article-title":"Antimicrobial susceptibility and phylogenetic relations in a German cohort infected with Mycobacterium abscessus","author":"Wetzstein","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0027","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijid.2020.06.007","article-title":"In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex","volume":"97","author":"Shirata","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0028","first-page":"77","article-title":"Underutilization of nontuberculous mycobacterial drug susceptibility testing in Ontario, Canada, 2010\u20132015","volume":"5","author":"Andrews","year":"2020","journal-title":"Off J Assoc Med Microbiol Infect Dis Canada"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02234-18","article-title":"In vitro synergism of rifabutin with clarithromycin, imipenem, and tigecycline against the Mycobacterium abscessus complex","volume":"63","author":"Cheng","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2018.08.008","article-title":"Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens","volume":"93","author":"Cho","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jiac.2018.10.010","article-title":"Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae","volume":"25","author":"Aono","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4902941","article-title":"In vitro susceptibility of mycobacterium abscessus and Mycobacterium fortuitum isolates to 30 antibiotics","volume":"2018","author":"Shen","year":"2018","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116435_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy022","article-title":"Mycobacterium abscessus complex infections: a retrospective cohort study","volume":"5","author":"Sfeir","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116435_bib0034","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/jac\/dkx212","article-title":"Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan","volume":"72","author":"Lee","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2298-8","article-title":"Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan","volume":"17","author":"Hatakeyama","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116435_bib0036","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmi.2014.10.018","article-title":"Rapidly growing mycobacteria in Singapore, 2006\u20132011","volume":"21","author":"Tang","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116435_bib0037","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/2109.141634","article-title":"Mycobacterium abscessus Complex Infections in Humans","volume":"21","author":"Lee","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116435_bib0038","first-page":"1","article-title":"Drug susceptibility testing of 31 antimicrobial agents on rapidly growing mycobacteria isolates from China","volume":"2015","author":"Pang","year":"2015","journal-title":"BioMed Res Int"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116435_bib0039","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200905-0704OC","article-title":"Antibiotic treatment of Mycobacterium abscessus lung disease","volume":"180","author":"Jeon","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116435_bib0040","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/AAC.47.6.1958-1962.2003","article-title":"High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan","volume":"47","author":"Yang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116435_bib0041","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (Formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0042","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12941-023-00637-4","article-title":"Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand","volume":"22","author":"Sukmongkolchai","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0043","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1080\/07853890.2022.2121984","article-title":"Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract","volume":"54","author":"He","year":"2022","journal-title":"Ann Med"},{"issue":"6014","key":"10.1016\/j.diagmicrobio.2024.116435_bib0044","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/bmj.1.6014.880","article-title":"Serum levels of doxycycline in normal subjects after a single oral dose","volume":"1","author":"Adadevoh","year":"1976","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116435_bib0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200905-0704OC","article-title":"Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients","volume":"180","author":"Jeon","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116435_bib0046","first-page":"462","article-title":"Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections \u00e0 Mycobact\u00e9ries","volume":"2","author":"Roussel","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116435_bib0047","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/AAC.36.10.2104","article-title":"Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages","volume":"36","author":"Cohen","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0048","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","article-title":"US cystic fibrosis foundation and european cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116435_bib0049","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/1.3.323","article-title":"Activity of minocycline and tetracycline against respiratory pathogens related to blood levels","volume":"1","author":"Wood","year":"1975","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/13.1.93","article-title":"Absorption of minocycline","volume":"13","author":"Smith","year":"1984","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116435_bib0051","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/1.3.317","article-title":"A comparison of the bioavailability of minocycline capsules and film-coated tablets","volume":"1","author":"Cartwright","year":"1975","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116435_bib0053","first-page":"62","article-title":"Minocycline has no clear role in the treatment of Mycobacterium abscessus disease","author":"Ruth","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116435_bib0054","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus pulmonary disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116435_bib0056","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ijmr.IJMR_902_20","article-title":"Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases","volume":"152","author":"Sharma","year":"2020","journal-title":"Indian J Med Res"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116435_bib0057","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116435_bib0058","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1128\/AAC.01636-05","article-title":"Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections","volume":"50","author":"Van Wart","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116435_bib0059","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijantimicag.2016.12.008","article-title":"A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding","volume":"49","author":"Singh","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116435_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/AAC.00277-10","article-title":"Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia","volume":"56","author":"Rubino","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932400261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288932400261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:23:30Z","timestamp":1724163810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288932400261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S073288932400261X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116435","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116435"}}